Siga Technologies, INC.
At a glance
Employees20-99
In business sinceNot reported
HeadquartersNew York, NY
US patents56
SAM.gov UEIVJRNRTSL22K4
CAGE code1V4X4
Incorporated inDE
- medicines
- infectious diseases
- partnering
- governments
- organizations
- reports financial results
- declares
Named on the company’s own website, read JUL 29, 2026
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
56 US patents granted 2006–2024, 5 of them in the five years to SEP 2025.
Pharmaceuticals 48Organic fine chemistry 6Measurement 2
- Polymorphic forms of ST-246 and methods of preparationUS 11,890,270 · granted FEB 6, 2024
- ST-246 (tecovirimat monohydrate) suspension formulationsUS 11,779,566 · granted OCT 10, 2023
- ST-246 (tecovirimat monohydrate) suspension formulationsUS 11,433,051 · granted SEP 6, 2022
- Polymorphic forms of ST-246 and methods of preparationUS 10,933,050 · granted MAR 2, 2021
- ST-246 liquid formulations and methodsUS 10,864,282 · granted DEC 15, 2020
Newest 5 shown · Granted to Siga Technologies, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Siga Technologies, INC. | New York | NY | 20–99 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.